Burosumab

Tax included
Burosumab is a human fibroblast growth factor 23 (FGF23) neutralizing antibody that can be used for the research of X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia.
MedChemExpress 
HY-P9939

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
1610833-03-8